title: Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonist.
authors.affiliation: Abbott Laboratories, Abbott Park, Illinois 60064-3500, USA.
authors.forename: D H
authors.initials: DH
authors.lastname: Albert
authors.forename: T J
authors.initials: TJ
authors.lastname: Magoc
authors.forename: H D
authors.initials: HD
authors.lastname: Kleinert
authors.forename: E
authors.initials: E
authors.lastname: Sun
authors.forename: A E
authors.initials: AE
authors.lastname: Reyes
authors.forename: G W
authors.initials: GW
authors.lastname: Carter
authors.forename: J B
authors.initials: JB
authors.lastname: Summers
mesh_terms: D000293:Adolescent; D000328:Adult; D002851:Chromatography, High Pressure Liquid; D004311:Double-Blind Method; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D011355:Prodrugs / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D011726:Pyridinium Compounds / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D013056:Spectrophotometry, Ultraviolet; D013844:Thiazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D001620:beta-Thromboglobulin / Q000378:metabolism*
chemical_list: D010972:Platelet Activating Factor; D010975:Platelet Aggregation Inhibitors; D011355:Prodrugs; D011726:Pyridinium Compounds; D013844:Thiazoles; D001620:beta-Thromboglobulin; C093306:ABT 299